These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34276994)

  • 1. Cerebellar preference of luminal A and B type and basal ganglial preference of HER2-positive type breast cancer-derived brain metastases.
    Izutsu N; Kinoshita M; Ozaki T; Sakai M; Nakanishi K; Nakayama T; Tamaki Y; Kishima H
    Mol Clin Oncol; 2021 Sep; 15(3):175. PubMed ID: 34276994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtypes of breast cancer show different spatial distributions of brain metastases.
    Kyeong S; Cha YJ; Ahn SG; Suh SH; Son EJ; Ahn SJ
    PLoS One; 2017; 12(11):e0188542. PubMed ID: 29155879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular subtype predicts incidence and prognosis of brain metastasis from breast cancer in SEER database.
    Kim YJ; Kim JS; Kim IA
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1803-1816. PubMed ID: 29971531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.
    Dilorenzo G; Telegrafo M; La Forgia D; Stabile Ianora AA; Moschetta M
    Eur J Radiol; 2019 Apr; 113():148-152. PubMed ID: 30927939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different spatial distributions of brain metastases from lung cancer by histological subtype and mutation status of epidermal growth factor receptor.
    Takano K; Kinoshita M; Takagaki M; Sakai M; Tateishi S; Achiha T; Hirayama R; Nishino K; Uchida J; Kumagai T; Okami J; Kawaguchi A; Hashimoto N; Nakanishi K; Imamura F; Higashiyama M; Yoshimine T
    Neuro Oncol; 2016 May; 18(5):716-24. PubMed ID: 26519739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
    Wu SY; Tan Y; Guan YS
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological Subtypes and Distant Relapse Pattern in Breast Cancer Patients After Curative Surgery (Study of Anatolian Society of Medical Oncology).
    Kaplan MA; Arslan UY; Işıkdogan A; Dane F; Oksuzoglu B; Inanc M; Akman T; Kucukoner M; Cinkir HY; Rzazade R; Ozkan M; Yilmaz U; Bayoglu IV; Gunaydin Y; Baykara M; Yazilitas D; Cubukcu E; Suner A; Ersoy U; Bilici M; Yazici O; Cayır K; Demirci U; Uysal M
    Breast Care (Basel); 2016 Aug; 11(4):248-252. PubMed ID: 27721711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and prognosis of breast cancer patients with brain metastases according to intrinsic subtype.
    Kuba S; Ishida M; Nakamura Y; Yamanouchi K; Minami S; Taguchi K; Eguchi S; Ohno S
    Jpn J Clin Oncol; 2014 Nov; 44(11):1025-31. PubMed ID: 25156682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and survival analysis of different subtypes of patients with breast cancer brain metastases.
    Bai B; Yuan ZY; Liu DG; Teng XY; Wang SS
    Chin J Cancer; 2010 Apr; 29(4):413-9. PubMed ID: 20346218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer recurrence according to molecular subtype.
    Shim HJ; Kim SH; Kang BJ; Choi BG; Kim HS; Cha ES; Song BJ
    Asian Pac J Cancer Prev; 2014; 15(14):5539-44. PubMed ID: 25081661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of survival outcomes based on molecular subtypes in breast cancer brain metastases: A single institutional cohort.
    Jeon W; Jang BS; Jeon SH; Kim JH; Kim YJ; Kim SH; Kim CY; Han JH; Kim IA
    Breast J; 2018 Nov; 24(6):920-926. PubMed ID: 30596408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry.
    Park S; Koo JS; Kim MS; Park HS; Lee JS; Lee JS; Kim SI; Park BW
    Breast; 2012 Feb; 21(1):50-7. PubMed ID: 21865043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
    Liu ZF; Chen C; Yao XL; Sun SR
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT).
    Niwińska A; Murawska M; Pogoda K
    Ann Oncol; 2010 May; 21(5):942-8. PubMed ID: 19840953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overall survival and the response to radiotherapy among molecular subtypes of breast cancer brain metastases treated with targeted therapies.
    Miller JA; Kotecha R; Ahluwalia MS; Mohammadi AM; Chao ST; Barnett GH; Murphy ES; Vogelbaum MA; Angelov L; Peereboom DM; Suh JH
    Cancer; 2017 Jun; 123(12):2283-2293. PubMed ID: 28192598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer subtypes and response to systemic treatment after whole-brain radiotherapy in patients with brain metastases.
    Niwińska A; Murawska M; Pogoda K
    Cancer; 2010 Sep; 116(18):4238-47. PubMed ID: 20549816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast cancer brain metastases: clinical and prognostic characteristics of different biological subtypes].
    Zhang T; Li Q; Xu B; Zhang P; Yuan P; Ma F; Wang J; Fan Y
    Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):697-702. PubMed ID: 25564062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of breast cancer subtypes and patterns of metastasis on outcome.
    Kast K; Link T; Friedrich K; Petzold A; Niedostatek A; Schoffer O; Werner C; Klug SJ; Werner A; Gatzweiler A; Richter B; Baretton G; Wimberger P
    Breast Cancer Res Treat; 2015 Apr; 150(3):621-9. PubMed ID: 25783184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis.
    Niikura N; Hayashi N; Masuda N; Takashima S; Nakamura R; Watanabe K; Kanbayashi C; Ishida M; Hozumi Y; Tsuneizumi M; Kondo N; Naito Y; Honda Y; Matsui A; Fujisawa T; Oshitanai R; Yasojima H; Tokuda Y; Saji S; Iwata H
    Breast Cancer Res Treat; 2014 Aug; 147(1):103-12. PubMed ID: 25106661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of breast cancer relapse in accordance to biological subtype.
    Ignatov A; Eggemann H; Burger E; Ignatov T
    J Cancer Res Clin Oncol; 2018 Jul; 144(7):1347-1355. PubMed ID: 29675790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.